Clinical Trials Directory

Trials / Completed

CompletedNCT01456026

Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes

Acute Effects of Food Advanced Glycation Endproducts on Macrovascular Function in Subjects With Type 2 Diabetes Mellitus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Profil Institut für Stoffwechselforschung GmbH · Industry
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Recent evidence supports detrimental effects of advanced glycation endproducts (AGE) on vascular function (VF). Though, the effect of AGE-modified proteins alone on vascular function remained unknown. Therefore, the aim of our study is to investigate the effects of heat-treated, glycated beta-lactoglobulins (BLG) on vascular function in subjects with type 2 diabetes mellitus (T2DM) and to compare it to non-glycated, heat-treated BLG.

Detailed description

In a double-blind, controlled, randomized, cross-over manner, 19 subjects with T2DM will receive on 2 different days beverages containing either glycated, heat-treated BLG or non-glycated, heat-treated BLG. Macrovascular (brachial ultrasound of flow mediated dilatation -FMD) and microvascular function (laser-doppler measurements of reactive hyperemia at the hand) at baseline (T0), as well as 90 (T90) and 180 (T180) minutes after each beverage will be measured.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGlycated beta-lactoglobulins.oral, 20 g, single administration
DIETARY_SUPPLEMENTNon-glycated beta-lactoglobulins20 g, oral, single administration,

Timeline

Start date
2009-06-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2011-10-20
Last updated
2011-10-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01456026. Inclusion in this directory is not an endorsement.